Author:
Rebolj Matejka, ,Brentnall Adam R.,Mathews Christopher,Denton Karin,Holbrook Miles,Levine Tanya,Sargent Alexandra,Smith John,Tidy John,Tyler Xenia,Kitchener Henry
Funder
Cancer Research UK
Partly funded through Public Health England.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Kitchener, H. C. HPV primary cervical screening: time for a change. Cytopathology 26, 4–6 (2015).
2. Huh, W. K., Ault, K. A., Chelmow, D., Davey, D. D., Goulart, R. A., Garcia, F. A. et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol. Oncol. 136, 178–182 (2015).
3. Australian Government (Department of Health). Changes to the National Cervical Screening Program (NCSP) for Healthcare Providers From 1 December 2017.
http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/1-december-changes-fact-sheet
(2018).
4. Goodman, M. T., Shvetsov, Y. B., McDuffie, K., Wilkens, L. R., Zhu, X., Thompson, P. J. et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 68, 8813–8824 (2008).
5. Jaisamrarn, U., Castellsague, X., Garland, S. M., Naud, P., Palmroth, J., Del Rosario-Raymundo, M. R. et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS ONE 8, e79260 (2013).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献